Klorhex Plus Oral Spray

Klorhex Plus Oral Spray represents a dual-action pharmaceutical formulation combining antiseptic and anti-inflammatory properties through its active ingredients. This Turkish medication, manufactured by Drogsan İlaçları Sanayi ve Tic. A.Ş., offers therapeutic benefits for various oral and throat conditions. The formulation provides both antimicrobial protection and inflammation reduction, making it suitable for multiple applications in dental, surgical, and everyday oral care contexts.

Composition and Formulation

Klorhex Plus Oral Spray contains two primary active ingredients working synergistically to address oral health concerns. Each 30 ml of spray solution contains 0.075 g of flurbiprofen and 0.036 g of chlorhexidine digluconate. Flurbiprofen belongs to the non-steroidal anti-inflammatory drug (NSAID) class, providing anti-inflammatory and analgesic properties. Chlorhexidine digluconate functions as a powerful antiseptic agent with broad-spectrum antimicrobial activity.

The formulation also includes several auxiliary ingredients that enhance stability, palatability, and functionality. These include macrogol glycerin hydroxy stearate 40, glycerin (2.1 g per 30 ml), sodium saccharin (0.03 g per 30 ml), liquid sorbitol (10.5 g per 30 ml, non-crystalline 70%), Eco cool MP, peppermint essence, blue coloring additive E131 (Patent Blue V), sodium bicarbonate, ethanol (96%), and purified water. The solution presents as a blue-colored liquid in a spray format designed for targeted oral application.

Therapeutic Indications

Primary Applications

Klorhex Plus Oral Spray demonstrates versatility across multiple oral health scenarios. The medication is primarily indicated for oral and throat antisepsis, providing relief from symptoms associated with infections and inflammations of the oral cavity. It significantly aids in improving swallowing function for patients experiencing discomfort and serves as an effective symptom reliever for various gum disorders.

Specific Conditions

The dual-action formulation proves beneficial for inflammatory and microbial conditions affecting the oral cavity. This includes gingivitis (gum inflammation), stomatitis (oral mucosa inflammation), pharyngitis (throat inflammation), tonsillitis (tonsil inflammation), and aphthous lesions (mouth ulcers). The spray’s format allows for precise application to affected areas, enhancing its therapeutic efficacy in these conditions.

Preventive Applications

Beyond treatment of existing conditions, Klorhex Plus demonstrates prophylactic value in several contexts. It serves as a preventative measure before dental procedures, helping to reduce microbial load in the oral cavity. Recent clinical evidence also suggests effectiveness as a preemptive analgesic agent before surgical procedures such as rhinoplasty, significantly decreasing postoperative pain levels, sore throat symptoms, and hoarseness.

Mechanism of Action

The therapeutic efficacy of Klorhex Plus Oral Spray stems from the complementary mechanisms of its two active ingredients. Flurbiprofen, as a non-steroidal anti-inflammatory agent, inhibits the cyclooxygenase enzymes responsible for prostaglandin synthesis, thereby reducing inflammation, pain, and associated discomfort in affected oral tissues. This effect proves particularly beneficial in inflammatory conditions and post-surgical recovery.

Chlorhexidine digluconate provides potent antimicrobial action against a wide spectrum of microorganisms. It disrupts the bacterial cell membrane, leading to increased permeability and ultimately cell death. This antiseptic property helps prevent secondary infections, reduces microbial burden in the oral cavity, and addresses existing pathogenic colonization. The combination of these mechanisms creates a comprehensive approach to oral health management, addressing both infectious and inflammatory components simultaneously.

Dosage and Administration

Standard Dosage

The recommended regimen for Klorhex Plus Oral Spray involves direct application to affected areas. The standard dosage consists of 3 sprays administered 3 times daily to the relevant area. Each spray delivers approximately 0.13 ml of solution, corresponding to 0.325 mg of flurbiprofen and 0.156 mg of chlorhexidine. This measured dose ensures optimal therapeutic effect while minimizing potential adverse reactions.

Administration Guidelines

Klorhex Plus should be sprayed directly onto the affected areas of the mouth or throat. Importantly, the solution should not be swallowed after application, as it is designed for topical effect rather than systemic absorption. For maximum benefit, patients should avoid eating, drinking, or rinsing the mouth for at least 30 minutes following application, allowing the active ingredients sufficient contact time with oral tissues.

Duration of Treatment

The treatment duration varies depending on the condition being addressed. For general oral infections and inflammations, treatment typically continues until symptom resolution, usually within 5-7 days. For specific conditions like gingivitis, a treatment course of approximately one month may be advisable, though individual responses may necessitate adjustments.

Contraindications and Precautions

Absolute Contraindications

Several conditions absolutely preclude the use of Klorhex Plus Oral Spray. The medication should not be administered to individuals with known hypersensitivity to either flurbiprofen, chlorhexidine digluconate, or any auxiliary components in the formulation. Additionally, individuals with established hypersensitivity to acetylsalicylic acid or other non-steroidal anti-inflammatory drugs should avoid this medication due to potential cross-reactivity.

Patients with a history of bronchospasm, rhinitis, or urticaria triggered by acetylsalicylic acid or other NSAIDs represent another group for whom this medication is contraindicated. Those with active peptic ulcer disease or a history of this condition should also avoid Klorhex Plus due to potential exacerbation of gastric symptoms, even with topical application.

Cautionary Use

Certain populations require special consideration when using Klorhex Plus. Individuals with kidney failure, heart failure, or liver impairment should use the medication with caution and preferably under medical supervision. While the topical application limits systemic absorption, these conditions may still impact drug metabolism and clearance, potentially affecting safety profiles.

Special Populations

Pediatric Considerations

Klorhex Plus Oral Spray is explicitly contraindicated for children under 12 years of age. For adolescents between 12-18 years, administration should occur only under medical supervision and with appropriate dosage adjustments based on the individual’s condition and response to treatment.

Geriatric Use

Specific data regarding the use of Klorhex Plus in elderly populations remains limited. Without dedicated studies in geriatric patients, cautious approach is warranted, potentially with adjusted dosing schedules and increased monitoring for adverse effects. Physiological changes associated with aging may influence drug response and tolerance.

Pregnancy and Lactation

Klorhex Plus is contraindicated during pregnancy and breastfeeding periods. Neither flurbiprofen nor chlorhexidine has been conclusively established as safe during these periods, and the potential risks to fetal development or nursing infants outweigh potential benefits. Women who become pregnant during treatment should discontinue use immediately and consult healthcare providers.

Clinical Evidence and Effectiveness

Postoperative Applications

Recent clinical investigations have demonstrated significant efficacy of Klorhex Plus in managing postoperative complications. A retrospective study involving 354 rhinoplasty patients showed that preemptive application of Klorhex Plus Oral Spray significantly reduced postoperative pain levels measured at 1 hour, 12 hours, and 24 hours after surgery. The same study documented significantly lower incidences of postoperative sore throat (POST) and postoperative hoarseness (POH) in treated patients compared to controls.

Comparable Interventions

In comparative studies examining postoperative sore throat and hoarseness, flurbiprofen spray showed similar effectiveness to benzydamine hydrochloride spray, with both treatments proving significantly more effective than placebo in reducing symptom incidence and severity. Neither treatment group reported significant adverse effects, supporting the favorable safety profile of flurbiprofen-based oral sprays.

Side Effects

While generally well-tolerated when used as directed, Klorhex Plus may occasionally produce adverse reactions. Common side effects include mild and transient oral irritation, altered taste perception, and numbness or tingling sensation in the application area. Some patients may experience temporary yellow-brown discoloration of teeth or tongue due to the chlorhexidine component, though this typically resolves with discontinuation.

More serious but rare adverse effects include allergic reactions manifesting as rash, itching, or facial swelling. Extremely rare cases of anaphylaxis have been reported with chlorhexidine-containing products. Despite the topical application route, systemic absorption remains possible, potentially causing gastrointestinal disturbances in sensitive individuals. Any severe or persistent side effects warrant immediate medical attention and discontinuation of the product.

Drug Interactions

Potential Interactions

Despite its topical application, Klorhex Plus may interact with certain medications. Flurbiprofen has been observed to occasionally interact with anticoagulant medications, potentially enhancing their effects and increasing bleeding risk. However, significant interactions with digoxin, tolbutamide, and antacids have not been documented.

Formulation Incompatibilities

The chlorhexidine component demonstrates incompatibility with soap and other negatively charged (anionic) compounds, potentially reducing effectiveness when used concurrently. It also shows incompatibility with chloramphenicol antibiotics, certain inorganic salts, and some organic compounds. Patients should allow sufficient time between using Klorhex Plus and other oral care products to avoid potential inactivation of active ingredients.

Storage and Packaging

Klorhex Plus Oral Spray comes in a 30 ml high-density polyethylene (HDPE) white spray applicator bottle contained within a cardboard box packaging. The product should be stored at room temperature, away from direct light and heat sources. As with all medications, it should remain in its original packaging and be kept out of reach of children. The expiration date printed on the packaging should be strictly observed, and expired product should be properly disposed of according to local pharmaceutical waste guidelines.

Reference Table